What is Cerenome, Inc. (CNSY) stock price today?

Cerenome, Inc. (CNSY) is currently trading at $3.91, down 1.26% today.

What is CNSY P/E ratio?

Cerenome, Inc.'s P/E ratio is 0.18. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is Cerenome, Inc.'s market cap?

Cerenome, Inc. has a market capitalization of $26.91M.

NASDAQ · Medical - Pharmaceuticals

Cerenome, Inc. (CNSY) Stock

$3.91 -1.26% NASDAQ: CNSY Healthcare

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company.

Valuation

Metric	Value
Price	$3.91
Market Cap	$26.91M
P/E Ratio	0.18
P/B Ratio	2.24
P/S Ratio	5.19
EPS (TTM)	$21.72
52-Week High	$4.10
52-Week Low	$3.79
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	—
ROA	-73.82%
ROCE	—
Gross Margin	-83.09%
Operating Margin	-692.51%
Net Margin	-230.24%
Debt/Equity	0.06
Current Ratio	2.27

Latest News

Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform GlobeNewswire · Aug 6, 2026

Valuation & Return Ratios

Metric	Value
PEG Ratio	2.45
EV / EBITDA	-0.70
FCF Yield	—
Quick Ratio	2.07
Interest Coverage	—
Return 1Y	-80.80%
Return 3Y	-93.86%
Return 5Y	-99.51%

Ownership

Insiders Held1.84%

Institutions Held13.87%

Institutions Float Held14.12%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About Cerenome, Inc.

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Cerenome, Inc. is headquartered in US.

Cerenome, Inc. (CNSY) stock trades at $3.91 with a market capitalization of $26.91M. The stock is valued at a price-to-earnings (P/E) ratio of 0.18, price-to-book of 2.24, price-to-sales of 5.19. Over the past 52 weeks the stock has ranged between $3.79 and $4.10, and currently trades 4.6% below its 52-week high.

On profitability, Cerenome, Inc. generates an operating margin of -692.51%, a net profit margin of -230.24%.

Official website: www.plustherapeutics.com